IP Library Granted Patent US 11,110,398
Granted Patent B2
US 11,110,398 · App. 15/750,218 · Granted Sep 7, 2021

Method for enhancing filtration yields in tangential flow filtration system

Inventors: Sasi Kumar Nutalapati (Bangalore, IN); Klaus Gebauer (Uppsala, SE); Karl Axel Jakob Liderfelt (Uppsala, SE); Nachiket Karmarkar (Bangalore, IN); Ajit S. Vernekar (Bangalore, IN); Amit Kumar Sharma (Bangalore, IN); Fredrik Oskar Lundstrom (Uppsala, SE); Sangeetha Raghu Ramachandran (Bangalore, IN)
Assignee: Cytiva Sweden AB
B01D61/18B01D61/08B01D61/10B01D61/12B01D61/20B01D61/22B01D65/02C07K1/34B01D2311/08B01D2311/16B01D2311/25B01D2313/243B01D2315/10B01D2315/14B01D2321/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,110,398
App. No.
15/750,218
Granted
Sep 7, 2021
Kind
B2
Abstract

The disclosure generally relates to methods and apparatus for the efficient quantitative recovery of valuable biological fluids from filtration systems, more particularly to efficient quantitative recovery of valuable biological fluids from high precision separation systems suitable for use in the pharmaceutical and biotechnology industries.

Claims (17)

1. A process for enhanced recovery of a biological fluid from an activated crossflow filtration system, the process comprising:

a. inducing an internalized pressurized countercurrent flow throughout the activated crossflow filtration system by activating an internal pump fluidically coupled to a sterile air source at a first end of the activated crossflow filtration system to cause said biological fluid to flow in a flow direction from the sterile air source toward a drain valve and opposite to a crossflow direction,

b. recovering said biological fluid at the drain valve fluidically coupled at a second end opposite the first end of the activated crossflow filtration system,

wherein the crossflow direction is along a fluid loop from a biofluid source container to a crossflow filtration filter and back to the biofluid source container,

wherein the activating of the internal pump causes sterile air from the sterile air source to be introduced into the fluid loop between the biofluid source container and the crossflow filtration filter, and

wherein said inducing of the internalized pressurized countercurrent flow comprises supplying sterile air from the sterile air source passively.

2. The process according to claim 1 , wherein said internal pump is a peristaltic pump.

3. The process according to claim 1 , wherein said activated crossflow filtration system comprises a series of tubes, valves, sensors, and conduits connected together to form a flowpath.

4. The process according to claim 1 , wherein said internal pump is located adjacent to the biofluid source container.

5. The process according to claim 1 , wherein activating said internal pump comprises operating said internal pump between 10-10,000 rpm.

6. The process according to claim 1 , wherein activating said internal pump comprises operating said internal pump between 100-1000 rpm.

7. The process according to claim 1 , wherein activating said internal pump comprises operating said internal pump to generate an air flow output of from 1 mL/min to 1 L/min.

8. The process according to claim 7 , wherein said internal pump generates pressure between 1 psi to 150 psi.

9. The process according to claim 7 , wherein said internal pump generates pressure between 14 to 100 psi.

10. The process according to claim 1 , wherein said internal pump generates pressure between 14 to 50 psi.

11. The process according to claim 1 for enhanced recovery of a biological fluid from the activated crossflow filtration system wherein said internal pump induces air flow at about 2 L/min.

12. The process according to claim 1 for enhanced recovery of a biological fluid from the activated crossflow filtration system wherein said induction of the internalized pressurized countercurrent flow is about 25% of a maximum flow rate.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054262/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2018
From: NUTALAPATI, SASI KUMAR; KARMARKAR, NACHIKET; SHARMA, AMIT KUMAR; VERNEKAR, AJIT S.; RAGHU RAMACHANDRAN, SANGEETHA; GEBAUER, KLAUS HEINRICH; LIDERFELT, KARL AXEL JACOB; LUNDSTROM, FREDRIK OSKAR
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 044827/0625 →
Priority Claims (2)
IN 2581/DEL/2015 · Aug 20, 2015 · national
IN 2610/DEL/2015 · Aug 21, 2015 · national
Continuity (1)
Related Publication 20180221822A1 · Aug 9, 2018
Cited By (1)
US 12,427,454